Agile Therapeutics, Inc. announced that Ajit S. Shetty, Ph.D., has been appointed to the company's Board of Directors, effective February 24, 2016. Dr. Shetty will serve on Agile's Science & Technology and Nominating & Governance Committees. Dr. Shetty spent 36 years at Johnson & Johnson (“J&J”) in a wide range of global roles.

From 2007 to 2012, he served as Corporate Vice President Enterprise Supply Chain reporting to the CEO and was responsible for the transformation and optimization of J&J's supply chain. The company announced that Andrew Schiff, M.D., has stepped down from his role on the company's Board of Directors effective February 24, 2016, in order to devote his full time efforts to his other commitments. In connection with Dr. Shetty's appointment and Dr. Schiff's resignation, the company's Board of Directors appointed John Hubbard, Ph.D., FCP, a current director of the Company, to serve as a member of the Board's Audit Committee in place of Dr. Schiff, and replaced Dr. Hubbard on the Board's Nominating and Corporate Governance Committee with Dr. Shetty.